查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1684437

免疫血液学市场，按类型、按应用、按最终用户、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Immunohematology Market, By Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年免疫血液学市场规模价值 26.0943 亿美元，2025 年至 2032 年期间复合年增长率为 7.82%。

免疫血液学市场-市场动态

免疫血液学市场受到血液疾病和慢性病发病率增加的推动。根据世界卫生组织统计，全球约有16.2亿人患有贫血。这些案例强调了先进的血液检测和输血服务的重要性。此外，全球外科手术数量的增加也增加了对血液製品和免疫血液学服务的需求。提高意识和政府推动捐血的措施增加了血液製品的供应，从而刺激了市场扩张。结合次世代定序和聚合酶链反应 (PCR) 提高了免疫血液学诊断的准确性，从而鼓励其在临床环境中得到更广泛的应用。

新兴市场对免疫血液学产业具有巨大的成长潜力。发展中国家对医疗保健基础设施的投资将用于改善诊断和输血服务。此外，随着个人化医疗和针对患者的血液管理方法的日益普及，专门的免疫血液学产品和服务在市场上找到了发展空间。公私合作提高捐血意识和安全标准也将有利于市场成长。然而，先进诊断设备的高成本以及操作复杂诊断仪器的高技能人员可能会阻碍市场的发展。此外，有关血液製品和诊断设备的规定通常非常严格，通常会延迟产品註册和进入市场，可能影响新解决方案的及时上市。

免疫血液学市场-关键见解

试剂是市场上最大的细分市场，因为它们在血型分型和交叉配血中用途广泛，原因之一是市场对优质、可靠试剂的需求不断增长。

医院是免疫血液学市场最大的组成部分，因为医院拥有现代化的诊断设施和熟练的人员，可以为患者进行复杂的免疫血液学测试。

北美凭藉着更完善的医疗保健结构、更多的输血程序以及顶级竞争对手的领导地位引领市场。

由于卫生系统的不断改善、民众献血意识的提高以及卫生技术投资的推动，亚太地区成长最快。

免疫血液学市场-細項分析：

全球免疫血液学市场根据类型、应用、最终用户和地区进行细分。

根据类型，免疫血液学市场分为分析仪和试剂。试剂部分占据市场主导地位。血型鑑定、交叉配血和筛检过程依赖试剂；从而获得了统治权。患者群体中血液疾病发生率的增加以及输血频率的增加，对血库试剂盒的依赖要求越来越高，试剂盒的准确度也越来越高。这些试剂在医院、血库和诊断实验室中被广泛使用，以确保输血的兼容性并治疗溶血性疾病，凸显了这些试剂的重要性。预计预测期内分析仪部分将成长最快。这是因为对于在血液检测过程中提供更好的精度、更快的周转时间和更有效率的工作流程的自动和半自动分析仪的需求不断增长。全球实验室自动化趋势是推动分析仪领域成长的最重要因素之一。

根据最终用途，免疫血液学市场分为血库、医院、诊断和参考实验室以及学术和研究机构。医院是免疫血液学市场最大的部分。这是因为医院在病患照护中至关重要，在手术和创伤期间，血型鑑定、交叉配血和输血服务通常至关重要。医院还拥有现代化的诊断设备和熟练的人员，可以进行复杂的免疫血液学测试来管理患者。血库部门预计在预测期内将呈现最高的复合年增长率。这主要是由于人们认识的提高和相关计划鼓励人们选择自愿捐献，以及血库和采集中心的扩大。血库已变得不可避免，因为它们构成并维持着有保障的充足供应，并且需要在其运作中利用最新的免疫血液学技术来检测感染并保持相容性。血库的发展（尤其是第三世界国家的血库）提高了安全输血的普及率，进一步推动了市场的成长。

免疫血液学市场-地理洞察

北美市场占据主导地位，占有相当大的份额。医疗保健系统的先进基础设施、技术的最大利用以及每年大量的输血解释了这里的份额。根据美国疾病管制与预防中心记录，美国每年平均输血量约为 1,460 万单位，显示该地区对免疫血液学相关产品和服务的需求非常高。对这个市场做出贡献的主要国家包括美国和加拿大，这两个国家以完善的医疗保健体系和对医疗创新的持续投资而闻名。预计预测期内亚太地区将经历最快的成长。这是由于医疗保健支出的增加、捐血意识的增强以及血液相关疾病的增加。印度和中国等国家最近改善了其卫生基础设施和输血服务，世界卫生组织观察到此类变化正在增加。这些趋势使中国、印度和日本等国家处于这个不断增长的市场的前沿，并且很可能继续在免疫血液学实践方面取得很大进展。

免疫血液学市场-竞争格局：

全球免疫血液学市场竞争激烈，有少数关键参与者正在推动创新并扩大其市场足迹。市场领先的公司包括 Bio-Rad Laboratories, Inc.、Immucor、Ortho Clinical Diagnostics、Grifols 和 BD（Becton Dickinson），它们凭藉广泛的产品组合和强大的分销网络占据了市场主导地位。这些参与者专注于开发先进的免疫血液学解决方案，例如自动分析仪、试剂和分子诊断，以提高诊断的准确性和效率。策略合作、合併和收购是扩大产品供应和渗透新兴市场的常见策略。透过与医疗机构和血库合作，公司还可以满足亚太地区和拉丁美洲日益增长的市场需求。旨在开发新一代免疫血液学技术的研发投资增强了市场的竞争格局。这种动态环境可能会推动免疫血液学领域的进一步发展。

最新动态：

2024年4月：Grifols在获得相关部门批准后，在中国市场推出了Erytra Eflexis自动血型分析技术。它使血型鑑定过程自动化并提高血库的效率。

2023 年 5 月：Bio-Rad Laboratories, Inc. 推出了自动化身分证系统 IH-500TM NEXT 系统。该系统提高了血型检测的灵敏度以及抗体的筛检。

2023 年 11 月：Versiti 收购了位于印第安纳波利斯的血液管理软体公司 Pearl Pathways。这将有助于 Versiti 提高其数位化能力并更好地管理血液供应链。

2023 年 7 月：QuidelOrtho 与 BYG4lab 合作，丰富其资讯学产品。此次合作的重点是为血库和输血中心开发新的软体产品。

目录

第 1 章：免疫血液学市场概述

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • 免疫血液学市场片段（按类型）
    • 免疫血液学市场片段（按应用）
    • 免疫血液学市场片段（按最终用户）
    • 免疫血液学市场片段（按国家/地区）
    • 免疫血液学市场片段（按地区）
  • 竞争洞察

第 3 章：免疫血液学主要市场趋势

  • 免疫血液学市场驱动因素
    • 市场驱动因素的影响分析
  • 免疫血液学市场限制
    • 市场限制的影响分析
  • 免疫血液学市场机会
  • 免疫血液学市场未来趋势

第 4 章：免疫血液学产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第 5 章：免疫血液学市场：地缘政治紧张局势升级的影响

  • 新冠肺炎疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第 6 章：免疫血液学市场格局

  • 2024 年免疫血液学市场份额分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：免疫血液学市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 分析器
    • 试剂

第 8 章：免疫血液学市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 抗体筛选
    • 血型

第 9 章：免疫血液学市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 血库
    • 医院
    • 诊断与参考实验室
    • 学术及研究机构

第 10 章：免疫血液学市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美免疫血液学主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按类型）
    • 北美市场规模与预测，按应用划分
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲免疫血液学主要製造商
    • 欧洲市场规模及预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区免疫血液学主要製造商
    • 亚太地区市场规模及预测（依国家/地区划分）
    • 亚太地区市场规模及预测（按类型）
    • 亚太地区市场规模及预测（按应用划分）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲免疫血液学主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按类型）
    • 拉丁美洲市场规模及预测（按应用划分）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲 (MEA)
    • 概述
    • 中东和非洲免疫血液学主要製造商
    • MEA 市场规模及预测（依国家/地区划分）
    • MEA 市场规模和预测（按类型）
    • MEA 市场规模及预测（按应用）
    • MEA 市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 11 章：免疫血液学产业主要供应商分析

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Bio-Rad Laboratories, Inc.
    • Immucor
    • Ortho Clinical Diagnostics
    • Grifols
    • BD (Becton Dickinson)
    • Hologic, Inc.
    • Siemens Healthineers
    • ThermoFisher
    • Abbott
    • Beckman Coulter, Inc.

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4745

REPORT HIGHLIGHT

Immunohematology Market size was valued at US$ 2,609.43 Million in 2024, expanding at a CAGR of 7.82% from 2025 to 2032.

Immunohematology, more often referred to as blood banking or transfusion medicine, is the area of hematology and immunology that studies antigens and antibodies related to blood. This is one of the most indispensable healthcare fields, mainly focused on the identification and compatibility of blood for transfusions, and understanding the disorders that might be associated with immune reactions in the blood. The general theme for this field refers to the detection, characterization, and clinical implications of blood group antigens and their corresponding antibodies. The immunohematology foundation lies in ABO and Rh blood group systems, which are critical for blood compatibility determination. Immunohematology tests entail cross-matching, screening irregular antibodies, and detecting antigens predisposing individuals to adverse reactions related to transfusions or pregnancy. Such includes the hemolytic disease of the fetus and the newborn. Modern medicine could hardly do without it since applying blood and other blood products guarantees the treatment of numerous diseases- from traumas and surgeries, through anemias, to chronic diseases.

Immunohematology Market- Market Dynamics

The immunohematology market is driven by increased incidence of hematological disorders and chronic diseases. According to the World Health Organization, anemia has affected around 1.62 billion people globally. Such cases emphasize the importance of advanced blood testing and transfusion services. Moreover, the increased number of surgical procedures worldwide contributes to the demand for blood products & immunohematology services. Propelling awareness and government initiatives promoting blood donation have increased the availability of blood products, thereby stimulating market expansion. Incorporating next-generation sequencing and polymerase chain reaction (PCR) has improved the accuracy of immunohematology diagnostics, encouraging increased adoption in clinical settings.

Emerging markets hold significant growth potential for the immunohematology industry. Developing countries' investment in healthcare infrastructure would be targeted towards improving diagnostics & blood transfusion services. Moreover, with the increasing popularity of personalized medicine and the patient-specific approach toward blood management, specialized immunohematology products and services can find a scope in the market. Public-private collaborations to increase blood donation awareness and safety standards will also favor market growth. However, the high costs for advanced diagnostic equipment and the highly skilled personnel operating complex diagnostic instruments will likely hinder the market. Furthermore, regulations often very stringent concerning blood products and diagnostic devices usually delay product registration and entry to the market, possibly affecting the prompt availability of new solutions.

Immunohematology Market- Key Insights

Reagents segment is the largest in the market, because of their immense usage in blood typing and cross-matching, one of the reasons being the growth in demand for quality and reliable reagents.

Hospitals are the largest segment of the immunohematology market since hospitals have modern diagnostic facilities and skilled personnel who can perform intricate immunohematology tests for patient management.

North America leads the market, based on a better-established healthcare structure, a more significant number of blood transfusion procedures, and leadership of top competition.

Asia Pacific is growing fastest due to continuous improvement in health systems, blood donation awareness among the population, and health technology investment push.

Immunohematology Market- Segmentation Analysis:

The Global Immunohematology Market is segmented on the basis of Type, Application, End User, and Region.

By type, the immunohematology market is divided into analyzers and reagents. The reagent segment dominates the market. Blood grouping, cross-matching, and the screening process depend on reagents; hence, it gains the domination power. Increased incidence of hematological disease in the patient population, together with the frequency of blood transfusions, has highly demanded that blood banks depend upon the blood banking reagent kits having increased accuracy levels in the reagent kits. Widespread usage in hospitals, blood banks, and diagnostic laboratories for ensuring compatibility in blood transfusions and managing hemolytic diseases has emphasized the importance of these reagents. The analyzers segment is expected to grow the fastest during the forecast period. This is due to the growing demand for automated & semi-automated analyzers that offer better precision, quicker turnaround times, and efficient workflow in blood testing procedures. The global trend towards automation in laboratories has been one of the most significant factors driving the growth of the analyzers segment.

By end use, the immunohematology market is divided into blood banks, hospitals, diagnostic and reference laboratories, and academic and research institutes. Hospitals are the largest segment of the immunohematology market. This is because hospitals are critical in patient care, where blood typing, cross-matching, and transfusion services are often essential during surgery and trauma. Hospitals also have modern diagnostic facilities and skilled personnel who can perform intricate immunohematology tests for patient management. The blood banks segment is projected to exhibit the highest CAGR during the forecast period. This is mainly due to heightened awareness and associated programs encouraging people to opt for voluntary donations, followed by an expansion of blood banks and collection centers. Blood banks have become unavoidable as they constitute and sustain a secured adequate supply and need to avail themselves of the latest immunohematology in their operations to detect infections while being compatible. Development in blood banks- especially in third-world countries, allows for increased penetration of safe blood transfusions, further propelling market growth.

Immunohematology Market- Geographical Insights

The North American market dominates, having a substantial presence. Advanced infrastructure of healthcare delivery systems and maximum utilization of technology with significant amounts of transfusion per annum explain the share here. The United States is claimed to transfuse an average of around 14.6 million units every year in blood as transcribed by the CDC, marking this region very highly for requiring products and services related to immunohematology. Leading nations contributing to this market include the US & Canada, known for their solid healthcare systems and continuous investment in medical innovations. The Asia-Pacific region is expected to experience the fastest growth during the forecast period. This is due to propelling healthcare expenditure, increased awareness regarding blood donation, and increased blood-related disorders. Countries such as India & China have recently improved their health infrastructure & blood transfusion services, with the WHO observing that such changes are increasing. These trends put countries like China, India, and Japan at the forefront of this growing market and are likely to continue with much improvement in the practice of immunohematology.

Immunohematology Market- Competitive Landscape:

The global immunohematology market is highly competitive, with the presence of a few key players who are driving innovation and expanding their market footprint. The leading companies in the market include Bio-Rad Laboratories, Inc., Immucor, Ortho Clinical Diagnostics, Grifols, and BD (Becton Dickinson), which have dominated the market due to their extensive product portfolios & robust distribution networks. These players focus on developing advanced immunohematology solutions, such as automated analyzers, reagents, and molecular diagnostics, to enhance diagnostic accuracy & efficiency. Strategic collaborations, mergers, and acquisitions are common strategies used to expand product offerings and penetrate emerging markets. Companies are also able to provide increasing markets in Asia-Pacific and Latin America by partnering with healthcare institutions and blood banks. Investments in research and development, aiming to develop new-generation immunohematology technologies, add to the market's competitive landscape. This dynamic environment is likely to propel further developments in the immunohematology sector.

Recent Developments:

April 2024: Grifols launched the Erytra Eflexis automated blood-typing technology in the Chinese market after approval from the appropriate authorities. It automates processes in blood typing and enhances efficiency at blood banks.

May 2023: Bio-Rad Laboratories, Inc. launched the IH-500TM NEXT System, an automated ID-Card system. The system is an improvement of blood type testing sensitivity as well as screening for antibodies.

November 2023: Versiti bought Pearl Pathways, a Indianapolis-based blood management software company. This will help Versiti improve their digital capabilities and better manage the blood supply chain.

July 2023: QuidelOrtho partners with BYG4lab to enrich its Informatics Offerings. The collaboration will focus on creating new software products for blood banks and transfusion centers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOHEMATOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Bio-Rad Laboratories, Inc.
  • Immucor
  • Ortho Clinical Diagnostics
  • Grifols
  • BD (Becton Dickinson)
  • Hologic, Inc.
  • Siemens Healthineers
  • ThermoFisher
  • Abbott
  • Beckman Coulter, Inc.

GLOBAL IMMUNOHEMATOLOGY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Analyzers
  • Reagents

GLOBAL IMMUNOHEMATOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Antibody Screening
  • Blood Typing

GLOBAL IMMUNOHEMATOLOGY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Blood Banks
  • Hospitals
  • Diagnostic and Reference Laboratories
  • Academic and Research Institutes

GLOBAL IMMUNOHEMATOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Immunohematology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immunohematology Market Snippet By Type
    • 2.1.2. Immunohematology Market Snippet by Application
    • 2.1.3. Immunohematology Market Snippet By End User
    • 2.1.4. Immunohematology Market Snippet by Country
    • 2.1.5. Immunohematology Market Snippet by Region
  • 2.2. Competitive Insights

3. Immunohematology Key Market Trends

  • 3.1. Immunohematology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immunohematology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immunohematology Market Opportunities
  • 3.4. Immunohematology Market Future Trends

4. Immunohematology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immunohematology Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Immunohematology Market Landscape

  • 6.1. Immunohematology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immunohematology Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Analyzers
    • 7.1.3. Reagents

8. Immunohematology Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Antibody Screening
    • 8.1.3. Blood Typing

9. Immunohematology Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Blood Banks
    • 9.1.3. Hospitals
    • 9.1.4. Diagnostic and Reference Laboratories
    • 9.1.5. Academic and Research Institutes

10. Immunohematology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Immunohematology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Immunohematology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Immunohematology Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Immunohematology Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Immunohematology Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Immunohematology Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Bio-Rad Laboratories, Inc.
    • 11.2.2. Immucor
    • 11.2.3. Ortho Clinical Diagnostics
    • 11.2.4. Grifols
    • 11.2.5. BD (Becton Dickinson)
    • 11.2.6. Hologic, Inc.
    • 11.2.7. Siemens Healthineers
    • 11.2.8. ThermoFisher
    • 11.2.9. Abbott
    • 11.2.10. Beckman Coulter, Inc.

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us